WO2006024523A1 - Dérivés de phtalamide s'utilisant comme insecticides - Google Patents

Dérivés de phtalamide s'utilisant comme insecticides Download PDF

Info

Publication number
WO2006024523A1
WO2006024523A1 PCT/EP2005/009392 EP2005009392W WO2006024523A1 WO 2006024523 A1 WO2006024523 A1 WO 2006024523A1 EP 2005009392 W EP2005009392 W EP 2005009392W WO 2006024523 A1 WO2006024523 A1 WO 2006024523A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
crc
alkylthio
halogen
cyano
Prior art date
Application number
PCT/EP2005/009392
Other languages
English (en)
Inventor
Anthony Cornelius O'sullivan
William Lutz
André Jeanguenat
Michael J. Robson
Steve Smith
Original Assignee
Syngenta Participation Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participation Ag filed Critical Syngenta Participation Ag
Publication of WO2006024523A1 publication Critical patent/WO2006024523A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/66Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/20All rings being cycloaliphatic the ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Definitions

  • the present invention relates to phthalamide derivatives, to processes for their preparation, to compositions comprising those compounds, and to their use for controlling insects or representatives of the order Acarina.
  • Phthalamide derivatives with insecticidal properties are known and described, for example, in EP-A-1006107, EP-A-1241159, WO 02/0947695 and EP-A-1215200.
  • X 1 is a chemical bond or is a CrC 4 -alkylene chain; each of Z 1 and Z 3 , which may be the same or different, represents hydrogen, halogen, nitro, cyano, CrC 8 alkyl, CrCshaloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -
  • Z 2 represents Ci-C 6 haloalkoxy or a group -C(R 1 R 2 J-R 3 ;
  • R 1 is halogen
  • R 2 is halogen or CrCe-haloalkyl
  • R 3 is halogen or d-C ⁇ -haloalkyl; each of Z 4 and Z 5 , which may be the same or different, represents halogen, cyano, C 1 -
  • Ri3, Ri 4 , Ri5, Ri6, Ri7 and R 18 independently of one another are C 1 -C 6 alkyl, C 1 -Ce haloalkyl, C 1 -C 6 alkylthio(C r C 4 ) alkyl, cyano(d- C 6 )alkyl, phenyKd-C ⁇ alkyl which may be mono-, di- or trisubstituted by R 19 , C 3 - Cscycloalkyl, C 3 -C 8 halocycloalkyl, C 3 -C 6 alkenyl, C 3 -C 6 haloalkenyl, C 3 -C 6 alkinyl or phenyl which may be mono-, di- or trisubstituted by R 19 ;
  • R 19 represents halogen, cyano, nitro, CrC 6 alkyl, CrC 6 haloalkyl, C 3 -C 6 cycloalkyl, C 3 - C 6 halocycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkinyl, C 2 -C 6 haloalkinyl, CrC 6 alkoxy, CrC 6 haloalkoxy, CrC ⁇ alkylthio, CrC 6 haloalkylthio, d-C ⁇ alkylsulfinyl, d-C ⁇ haloalkylsulfinyl, CrC 6 alkylsulfonyl, CrC 6 haloalkylsulfonyl, CrC 6 alkylamino, di(CrC 6 alkyl)amino, C 1 - Cealkoxycarbonyl, CrCehaloalkoxycarbonyl
  • Z 8 represents C 3 -C 6 cyanocycloalkyl, C 3 -C 6 nitrocycloalkyl, C 3 -C 6 cyanocycloalkenyl or C 3 - C 6 nitrocycloalkenyl; or
  • Z 8 represents C 3 -C 6 cycloalkyl, C 3 -C 6 cyanocycloalkyl, C 3 -C 6 nitrocycloalkyl, C 3 -C 6 halocyloalkyl, C 3 -C 6 cycloalkenyl, C 3 -C 6 cyanocycloalkenyl, C 3 -C 6 nitrocycloalkenyl or QrCehalocyloalkenyl, which are a) mono-, di- or trisubstituted by substituents selected from d-Csalkyl, C 2 -C 8 -alkenyl, C 2 - C 8 alkynyl and SiIyI(C 1 -C 4 -alkyl) 3 ; where said substituents for their part may be substituted by cyano, nitro, halogen, CrCealkylaminosulfonyl, di-(C 1 -C 6 alkylamino)sulfony
  • R 10 is hydrogen, hydroxy, C r C 6 alkyl, d-C 6 haloalkyl, d-Cealkoxy, d-C 6 alkylcarbonyl, d-C 6 alkoxycarbonyl or d-C 6 alkylsulfonyl; or - A -
  • Z 8 represents a seven- to twelve-membered monocarbocyclic, bridged or fused bicarbocyclic ring system, which is saturated or partially saturated, where c) said seven- to twelve-membered monocarbocyclic, bridged or fused bicarbocyclic ring system for its part may be mono-, di- or trisubstituted by substituents selected from C 1 - C 8 alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 alkynyl and SiIyI(C 1 -C 4 -alkyl) 3 ; where said substituents for their part may be substituted by cyano, nitro, halogen, CrC 6 alkylaminosulfonyl, di-(Ci- C 6 alkylamino)sulfonyl, or by a three- to ten-membered, monocyclic or fused bicyclic ring system, which may be aromatic, partially saturated or fully saturated and may contain from
  • R 12 is hydrogen, hydroxy, d-C 6 alkyl, d-C 6 haloalkyl, CrCealkoxy, d-C 6 alkylcarbonyl, d-C 6 alkoxycarbonyl or d-C 6 aIkylsulfonyl;
  • Z 6 is hydrogen or d-C 8 alkyl;
  • Z 7 is hydrogen, d-C 8 alkyl, C 2 -C 8 alkenyl or C 2 -C 8 alkynyl; and agronomically acceptable salts/isomers/enantiomers/tautomers of those compounds.
  • Compounds I which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrose acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as d-C 4 alkanecarboxylic acids which are unsubstitu- ted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with orga ⁇ nic sulfonic acids, such as d-C 4 alkane- or arylsulfonic acids which are unsubstitute
  • Com ⁇ pounds I which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as mor- pholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, die ⁇ thyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.
  • the corresponding internal salts can furthermore be formed.
  • agrochemically advantageous salts Preferred within the scope of the invention are agrochemically advantageous salts; however, the invention also encompasses salts which have disadvan ⁇ tage for agrochemical use, for example salts which are toxic to bees or fish, and which are employed, for example, for the isolation or purification of free compounds I or agrochemically utilizable salts thereof.
  • the free compounds I or their salts hereinabove and hereinbelow are respectively to be understood as including, where appropriate, the corresponding salts or the free compounds I.
  • the free form is preferred in each case.
  • a seven- to twelve-membered monocarbocyclic, bridged or fused bicarbocyclic ring system, which is saturated or partially saturated is preferably cycloheptyl, cyclooctyl, cycloheptenyl, cyclooctenyl, bicyclo[3.2.1Joctyl or bicyclo[4.1.0]heptyl.
  • Z 8 as C 3 -C 6 cycloalkyl or C 3 -C 6 cycloalkenyl is cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cylclopropenyl, cyclobutenyl, cyclopentenyl or cyclohexenyl.
  • alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso- butyl, tert-butyl, pentyl, hexyl, heptyl and octyl and their branched isomers.
  • Alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned.
  • the alkenyl and alkynyl groups can be mono- or polyunsaturated.
  • Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.
  • Haloalkyl groups preferably have a chain length of from 1 to 6 carbon atoms.
  • Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 ,1-difluoro- 2,2,2-trichloroethyI, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl; preferably trichloro- methyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl.
  • Suitable haloalkenyl groups are alkenyl groups which are mono- or polysubstituted by halogen, halogen being fluorine, chlorine, bromine and iodine and in particular fluorine and chlorine, for example 2,2-difluoro-1 -methylvinyl, 3-fluoropropenyl, 3-chloropropenyl, 3-bromopropenyl, 2,3,3-trifluoropropenyl, 2,3,3-trichloropropenyl and 4,4,4-trifluorobut-2-en- 1-yl.
  • halogen being fluorine, chlorine, bromine and iodine and in particular fluorine and chlorine, for example 2,2-difluoro-1 -methylvinyl, 3-fluoropropenyl, 3-chloropropenyl, 3-bromopropenyl, 2,3,3-trifluoropropenyl, 2,3,3-trichloropropenyl and 4,4,4-trifluorobut
  • Suitable haloalkynyl groups are, for example, alkynyl groups which are mono- or polysubstituted by halogen, halogen being bromine, iodine and in particular fluorine and chlorine, for example 3-fluoropropynyl, 3-chloropropynyl, 3-bromopropynyl, 3,3,3-trifluoro- propynyl and 4,4,4-trif luorobut-2-yn-1 -yl.
  • alkynyl groups which are mono- or polysubstituted by halogen preference is given to those having a chain length of from 3 to 5 carbon atoms.
  • Alkoxy groups preferably have a preferred chain length of from 1 to 6 carbon atoms.
  • Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the isomeric pentyloxy and hexyloxy radicals; preferably methoxy and ethoxy.
  • Alkylcarbonyl is preferably acetyl or propionyl.
  • Alkoxycarbonyl is, for example, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl or tert-butoxycarbonyl; preferably methoxycarbonyl or ethoxycarbonyl.
  • Haloalkoxy groups preferably have a chain length of from 1 to 8 carbon atoms.
  • Haloalkoxy is, for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2- trifluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2,2-difluoroethoxy and 2,2,2-trichloroethoxy; preferably difluoromethoxy, 2-chloroethoxy and trifluoromethoxy.
  • Alkylthio groups preferably have a chain length of from 1 to 8 carbon atoms.
  • Alkylthio is, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio and ethylthio.
  • Alkylsulfinyl is, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl, tert-butylsulfinyl; preferably methylsulfinyl and ethylsulfinyl.
  • Alkylsulfonyl is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl; preferably methylsulfonyl or ethylsulfonyl.
  • Alkoxyalkoxy groups preferably have a chain length of from 1 to 8 carbon atoms.
  • alkoxyalkoxy groups are: methoxymethoxy, methoxyethoxy, methoxypropoxy, ethoxymethoxy, ethoxyethoxy, propoxymethoxy or butoxybutoxy.
  • Alkylamino is, for example, methylamino, ethylamino, n-propylamino, isopropylamino or the isomeric butylamines.
  • Dialkylamino is, for example, dimethylamino, methylethylamino, diethylamino, n-propylmethylamino, dibutylamino and diisopropylamino.
  • Alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms.
  • Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl.
  • Alkylthioalkyl groups preferably have from 1 to 8 carbon atoms.
  • Alkylthioalkyl is, for example, methylthiomethyl, methylthioethyl, ethylthiomethyl, ethylthioethyl, n-propylthiomethyl, n-propylthioethyl, isopropylthiomethyl, isopropylthioethyl, butylthiomethyl, butylthioethyl or butylthiobutyl.
  • the cycloalkyl groups preferably have from 3 to 8 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
  • Phenyl also as part of a substituent such as phenoxy, benzyl, benzyloxy, benzoyl, phenylthio, phenylalkyl, phenoxyalkyl, may be substituted.
  • the substituents can be in ortho, meta and/or para position.
  • the preferred substituent positions are the ortho and para positions to the ring attachment point.
  • a three- to ten-membered, monocyclic or fused bicyclic ring system which may be aromatic, partially saturated or fully saturated is, for example, selected from the group consisting of cylclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, where said cycloalkylgroups for their part may be preferably unsubstituted or substituted by C 1 - C 6 alkyl or halogen, or is phenyl, naphthyl or the following heterocyclic groups: pyrrolyl; pyridyl; pyrazolyl; pyrimidyl; pyrazinyl; imidazolyl; thiadiazolyl; quinazolinyl; furyl; oxadiazolyl; indolizinyl; pyranyl; isobenzofuranyl; thienyl; naphthyridinyl; (1 -methyl- 1 H-pyrazol
  • each R 2 ⁇ is methyl
  • each R 27 and each R 2 s are independently hydrogen, C r C 3 alkyl, Ci-C 3 alkoxy, CrCsalkylthio or trifluoromethyl
  • CH carbon atom labelled "CH" or in a case such as, for example, at the bonding site indicated at the bottom left.
  • Z 2 is a group -C(RiR 2 )- R 3 , wherein R 1 is fluorine, R 2 is CrC- ⁇ fluoroalkyl, preferably fluoromethyl, most preferably trifluoromethyl and R 3 is d-Cefluoroalkyl, preferably fluoromethyl, most preferably trifluoromethyl.
  • R 3 and R 2 are fluorine.
  • Z 1 is hydrogen, halogen or C ⁇ C 4 alkyl and Z 3 is hydrogen.
  • a further outstanding group of compounds of formula I comprises those compounds wherein Z 1 is hydrogen, methyl or chlorine, Z 2 is -C(CF 3 ) 2 -F, Z 3 is hydrogen, Z 4 is hydrogen, Z 5 is chlorine, iodine or nitro, Z 6 is hydrogen, Z 7 is hydrogen, X 1 is a chemical bond and Z 8 is cyclopropyl which is mono- or di-substituted by C r C 6 alkyl, thienyl, furyl, phenyl, or by phenyl which itself is substituted by Ci-C 3 -alkyl, CrCehaloalkyl and/or halogen, or by pyridyl, which itself may be substituted by halogen or methyl, or by C 3 -C 6 cycloalkyl, C 2 -C 6 alkenyl, bicyclohexyl, bicyclohexyl substitute
  • Preferred compounds of formula I are those wherein Z 5 is halogen, preferably iodine or chlorine.
  • Especially interesting compounds of formula I are those wherein Z 8 is cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, each of which is mono-, di- or trisubstituted by methyl, ethyl, n- propyl, i-propyl or n-buthyl; or by C ⁇ C ⁇ alkyl substituted by cyano, nitro or halogen; or is mono-, di- or trisubstituted by phenyl, or by phenyl which itself is substituted by d-Ce-alkyl, CrC 6 haloalkyl and/or halogen, or by pyridyl, which itself may be substituted by halogen or methyl, or by furyl, thienyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkenyl, bicyclohexyl, bicyclohexyl substituted by d-C 3
  • Z 8 is cyclopropyl mono- or disubstituted by methyl or ethyl.
  • Z 1 , Z 2 , and Z 3 are defined as in formula I and Z 7 is hydrogen, in the presence of inert solvents and if appropriate, in the presence of a base, to a compound of formula IV
  • Z 1 , Z 2 , and Z 3 are defined as in formula I and Z 7 is hydrogen, which is converted with a condensing agent to a compound of formula V
  • Z 1 , Z 2 , Z 3 , Z 4 , and m are defined as in formula I and Z 7 is hydrogen , which is reacted in the presence of an inert solvent with a compound of formula Vl
  • lsoimides such as 7-iodo-3-[(Z)-2- methyl-4-(1 ,2,2,2-tetraf luoro-1 -trifluoromethyl-ethyl)-phenylimino]-3H-isobenzofuran-1 -one can be prepared according to EP 1006107, example 3-2.
  • Z 4 , m, Z 5 , X 1 and Z 8 are as defined in formula I and Z 6 is hydrogen, which is converted with a condensing agent to a compound of formula VIII wherein Z 4 , m, Z 5 , Xi and Z 8 are as defined in formula I and Z 6 is hydrogen, which is reacted with a compound of formula Ilia
  • Substituted cyclic amines can be prepared in many ways as described for example in Saul Patai "The Chemistry of the Amino Group” Wiley Interscience, London 1968. Cyclopropyl amines can be prepared in many ways as described for example in E-Vilsmaier, Aminocyclopropanes, Chapter 22 in "The Chemistry of the Cyclopropyl Group” Ed. Z Rapoport, John Wiley 1987. London p 1341.
  • the reactions described hereinabove and hereinbelow are carried out in a manner known per se, for example in the absence or, normally, in the presence of a suitable solvent or di ⁇ luent or of a mixture of these, the process being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of from approximately -80 0 C to the boiling point of the reaction mixture, preferably from approximately -2O 0 C to approximately +150 0 C, and, if required, in a sealed vessel, under reduced, normal or elevated pressure, in an inert gas atmosphere and/or under anhydrous conditions.
  • a suitable solvent or di ⁇ luent or of a mixture of these the process being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of from approximately -80 0 C to the boiling point of the reaction mixture, preferably from approximately -2O 0 C to approximately +150 0 C, and, if required, in a sealed vessel, under reduced, normal or elevated pressure
  • solvents or diluents which may be mentioned are: aromatic, aliphatic and alicyclic hydrocarbons and halohydrocarbons such as benzene, toluene, xylene, mesitylene, tetralin, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; esters such as ethyl acetate; ethers such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethyleneglycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxy
  • the starting materials mentioned hereinabove and hereinbelow, which are used for the preparation of the compounds I or, where appropriate, the tautomers thereof, in each case in free form or in salt form, are known or can be prepared by methods known per se, for example in accordance with the information given below.
  • a compound I can be converted in a manner known per se into another compound I by replacing one or more substituents of the starting compound I in the customary manner by (an)other substituent(s) according to the invention.
  • Salts of compounds I can be prepared in a manner known per se.
  • acid addition salts of compounds I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.
  • Salts of compounds I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.
  • Salts of compounds I can be converted in a manner known per se into other salts of compounds I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.
  • a salt of inorganic acid such as hydrochloride
  • a suitable metal salt such as a sodium, barium or silver salt
  • the compounds I which have salt- forming properties can be obtained in free form or in the form of salts.
  • the compounds I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.
  • Diastereomer mixtures or racemate mixtures of compounds I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.
  • Enantiomer mixtures such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high- performance liquid chromatography (HPLC) on acetyl celulose, with the aid of suitable mi ⁇ croorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is com- plexed, or by conversion into diastereomeric salts, for example by reacting a basic end-pro ⁇ duct racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional cry ⁇ stallization based
  • Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereose- lective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.
  • the biologically more effective iso ⁇ mer for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological ac ⁇ tivity.
  • the compounds I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.
  • the invention relates to all those embodiments of the process by which, starting from a compound obtainable at any level of the process as starting material or intermediate, all or some of the missing steps are carried out or a starting material is used in the form of a deri ⁇ vative and/or salt and/or racemates or antipodes thereof or, in particular, is formed under the reaction conditions.
  • the compounds I according to the invention are preventively and/or curatively valuable ac ⁇ tive ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants.
  • the active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina.
  • the insecticidal or acaricidal activity of the active in ⁇ gredients according to the invention can manifest itself directly, i. e.
  • Examples of the abovementioned animal pests are: from the order Acarina, for example,
  • Haematopinus spp. Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.; from the order Coleoptera, for example,
  • Curculio spp. Dermestes spp., Diabrotica spp., Epilachna spp., Eremnus spp., Leptinotarsa decemlineata, Lissorhoptrus spp., Melolontha spp., Orycaephilus spp., Otiorhynchus spp.,
  • Aedes spp. Antherigona soccata, Bibio hortulanus, Calliphora erythrocephala, Ceratitis spp.,
  • Cimex spp. Distantiella theobroma, Dysdercus spp., Euchistus spp., Eurygaster spp., Lep- tocorisa spp., Nezara spp., Piesma spp., Rhodnius spp., Sahlbergella singularis, Scotino- phara spp. and Triatoma spp.; from the order Homoptera, for example,
  • Aleurothrixus floccosus Aleurothrixus floccosus, Aleyrodes brassicae, Aonidiella spp., Aphididae, Aphis spp., Aspi- diotus spp., Bemisia tabaci, Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Coccus hesperidum, Empoasca spp., Eriosoma larigerum, Erythroneura spp.,
  • Myzus spp. Nephotettix spp., Nilaparvata spp., Parlatoria spp., Pemphigus spp., Planococ- cus spp., Pseudaulacaspis spp., Pseudococcus spp., Psylla spp., Pulvinaria aethiopica,
  • Vespa spp. from the order Isoptera, for example,
  • Reticulitermes spp. from the order Lepidoptera, for example,
  • Ostrinia nubilalis Pammene spp., Pandemis spp., Panolis flammea, Pectinophora gossypi- ela, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Scir- pophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Synanthedon spp.,
  • Thaumetopoea spp. Tortrix spp., Trichoplusia ni and Yponomeuta spp.; from the order Mallophaga, for example,
  • Blatta spp. Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Periplaneta spp. and Schistocerca spp.; from the order Psocoptera, for example,
  • Liposcelis spp. from the order Siphonaptera, for example,
  • the active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especi ⁇ ally on useful plants and ornamentals in agriculture, in horticulture and in forests, or on or ⁇ gans, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some ca ⁇ ses even plant organs which are formed at a later point in time remain protected against these pests.
  • Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, to ⁇ matoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and
  • the active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella, Spodoptera littoralis, Mamestra, Cydia pomonella, Empoasca , Leptinotarsa, Chilo supressalis in cotton, vegetable, apples, vineyard, potatos, maize, rice and soya crops.
  • crops is to be understood as including also crops that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors) as a result of conventional methods of breeding or genetic engineering.
  • herbicides like bromoxynil or classes of herbicides
  • ALS inhibitors for example primisulfuron, prosulfuron and trifloxysulfuron
  • EPSPS 5-enol-pyrovyl-shikimate-3-phosphate-synthase
  • GS glutamine synthetase
  • imazamox by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® , Herculex I® and LibertyLink®.
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popliae; or insecticidal proteins from Bacillus thuringiensis, such as ⁇ -endotoxins, e.g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bi) or Cry9c, or vegetative insecticidal proteins (VIP), e.g. VIP1 , VIP2, VIP3 or VIP3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp.
  • insecticidal proteins for example insecticidal proteins from Bacillus cereus or Bacillus popliae
  • Bacillus thuringiensis such as ⁇ -endotoxins, e.g. CrylA(b), CrylA(c), CrylF, CrylF(a
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins
  • toxins produced by fungi such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins
  • agglutinins proteinase inhibitors, such as trypsine inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors
  • ribosome-inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecd
  • ⁇ -endotoxins for example CrylA(b), CrylA(c), CrylF, CryIF(a2), CryllA(b), CrylllA, CrylllB(bi) or Cry9c, or vegetative insecticidal proteins (VIP), for example VIP1 , VIP2, VIP3 or VIP3A
  • VIP vegetative insecticidal proteins
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ).
  • Truncated toxins for example a truncated CrylA(b), are known.
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • amino acid replacements preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of CrylllA055, a cathepsin-D-recognition sequence is inserted into a CrylllA toxin (see WO 03/018810).
  • Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-O 374 753, WO 93/07278, WO 95/34656, EP-A-O 427 529, EP-A-451 878 and WO 03/052073.
  • Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-O 367 474, EP-A-O 401 979 and WO 90/13651.
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CrylllB(bi) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a CrylllB(bi) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin);
  • transgenic crops are: 1. Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated CrylA(b) toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
  • MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified CrylllA toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-D-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a CrylllB(bi) toxin and has resistance to certain Coleoptera insects.
  • NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810.
  • NK603 x MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylA(b) toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-O 392 225).
  • PRPs pathogenesis-related proteins
  • Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-O 392 225, WO 95/33818, and EP-A-O 353 191.
  • the methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; the so-called "pathogenesis-related proteins" (PRPs; see e.g. EP-A- 0 392 225); antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).
  • ion channel blockers such as blockers for sodium and calcium channels
  • the viral KP1 , KP4 or KP6 toxins for example the viral KP1 , KP4 or KP6 toxins
  • stilbene synthases such as the viral K
  • the invention therefore also relates to pesticidal compositions such as emulsifiable concen ⁇ trates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, soluble powders, dispersible powders, wettable powders, dusts, granules or encapsulations in polymeric substances, which comprise - at least - one of the active ingredients according to the invention and which are to be selected to suit the intended aims and the prevailing circumstances.
  • pesticidal compositions such as emulsifiable concen ⁇ trates, suspension concentrates, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, soluble powders, dispersible powders, wettable powders, dusts, granules or encapsulations in polymeric substances, which comprise - at least - one of the active ingredients according to the invention and which are to be selected to suit the intended aims and the prevailing circumstances.
  • the active ingredient is employed in pure form, a solid active ingredi ⁇ ent for example in a specific particle size, or, preferably, together with - at least - one of the auxiliaries conventionally used in the art of formulation, such as extenders, for example sol ⁇ vents or solid carriers, or such as surface-active compounds (surfactants).
  • auxiliaries conventionally used in the art of formulation, such as extenders, for example sol ⁇ vents or solid carriers, or such as surface-active compounds (surfactants).
  • Suitable solvents are: unhydrogenated or partially hydrogenated aromatic hy ⁇ drocarbons, preferably the fractions C 8 to Ci 2 of alkylbenzenes, such as xylene mixtures, al ⁇ kylated naphthalenes or tetrahydronaphthalene, aliphatic or cycloaliphatic hydrocarbons, such as paraffins or cyclohexane, alcohols such as ethanol, propanol or butanol, glycols and their ethers and esters such as propylene glycol, dipropylene glycol ether, ethylene glycol or ethylene glycol monomethyl ether or ethylene glycol monoethyl ether, ketones, such as cyclohexanone, isophorone or diacetone alcohol, strongly polar solvents, such as N-me- thylpyrrolid-2-one, dimethyl sulfoxide or N,N-dimethylformamide, water, unepoxidized or ep
  • Solid carriers which are used for example for dusts and dispersible powders are, as a rule, ground natural minerals such as calcite, talc, kaolin, montmorillonite or attapulgite.
  • ground natural minerals such as calcite, talc, kaolin, montmorillonite or attapulgite.
  • highly disperse silicas or highly dis ⁇ perse absorbtive polymers are also possible to add highly disperse silicas or highly dis ⁇ perse absorbtive polymers.
  • Suitable particulate adsorptive carriers for granules are porous types, such as pumice, brick grit, sepiolite or bentonite, and suitable non-sorptive carrier materials are calcite or sand.
  • a large number of granulated materials of inorganic or organic nature can be used, in particular dolomite or comminuted plant residues.
  • Suitable surface-active compounds are, depending on the type of the active ingredient to be formulated, non-ionic, cationic and/or anionic surfactants or surfactant mixtures which have good emulsifying, dispersing and wetting properties.
  • the surfactants mentioned below are only to be considered as examples; a large number of further surfactants which are conven- tionally used in the art of formulation and suitable according to the invention are described in the relevant literature.
  • Suitable non-ionic surfactants are, especially, polyglycol ether derivatives of aliphatic or cyc- loaliphatic alcohols, of saturated or unsaturated fatty acids or of alkyl phenols which may contain approximately 3 to approximately 30 glycol ether groups and approximately 8 to approximately 20 carbon atoms in the (cyclo)aliphatic hydrocarbon radical or approximately 6 to approximately 18 carbon atoms in the alkyl moiety of the alkyl phenols.
  • water-soluble polyethylene oxide adducts with polypropylene glycol, ethylenediaminopo- lypropylene glycol or alkyl polypropylene glycol having 1 to approximately 10 carbon atoms in the alkyl chain and approximately 20 to approximately 250 ethylene glycol ether groups and approximately 10 to approximately 100 propylene glycol ether groups.
  • the abovementioned compounds contain 1 to approximately 5 ethylene glycol units per propy ⁇ lene glycol unit.
  • nonylphenoxypolyethoxyethanol examples which may be mentioned are nonylphenoxypolyethoxyethanol, castor oil polyglycol ether, polypropylene glycol/polyethylene oxide adducts, tributylpheno- xypolyethoxyethanol, polyethylene glycol or octylphenoxypolyethoxyethanol.
  • fatty acid esters of polyoxyethylene sorbitan such as polyoxyethylene sorbitan trioleate.
  • the cationic surfactants are, especially, quarternary ammonium salts which generally have at least one alkyl radical of approximately 8 to approximately 22 C atoms as substituents and as further substituents (unhalogenated or halogenated) lower alkyl or hydroxyalkyl or benzyl radicals.
  • the salts are preferably in the form of halides, methylsulfates or ethylsulfates. Examples are stearyltrimethylammonium chloride and benzylbis(2-chloroethyl)ethyl- ammonium bromide.
  • Suitable anionic surfactants are water-soluble soaps or water-soluble synthetic surface-active compounds.
  • suitable soaps are the alkali, alkaline earth or (un- substituted or substituted) ammonium salts of fatty acids having approximately 10 to appro ⁇ ximately 22 C atoms, such as the sodium or potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which are obtainable for example from coconut or tall oil; mention must also be made of the fatty acid methyl taurates.
  • synthetic surfactants are used more frequently, in particular fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylaryl sulfonates.
  • the fatty sulfonates and fatty sulfates are pre ⁇ sent as alkali, alkaline earth or (substituted or unsubstituted) ammonium salts and they ge- nerally have an alkyl radical of approximately 8 to approximately 22 C atoms, alkyl also to be understood as including the alkyl moiety of acyl radicals; examples which may be mentioned are the sodium or calcium salts of lignosulfonic acid, of the dodecylsulfuric ester or of a fatty alcohol sulfate mixture prepared from natural fatty acids. This group also includes the salts of the sulfuric esters and sulfonic acids of fatty alcohol/ethylene oxide adducts.
  • the sulfonated benzimidazole derivatives preferably contain 2 sulfonyl groups and a fatty acid radical of approximately 8 to approximately 22 C atoms.
  • alkylarylsulfonates are the sodium, calcium or triethanolammonium salts of decylbenzenesulfonic acid, of dibutyl- naphthalenesulfonic acid or of a naphthalenesulfonic acid/formaldehyde condensate.
  • suitable phosphates such as salts of the phosphoric ester of a p- nonylphenol/(4-14)ethylene oxide adduct, or phospholipids.
  • the compositions comprise 0.1 to 99%, especially 0.1 to 95%, of active ingredient and 1 to 99.9%, especially 5 to 99.9%, of at least one solid or liquid adjuvant, it being possible as a rule for 0 to 25%, especially 0.1 to 20%, of the composition to be surfactants (% in each case meaning percent by weight).
  • surfactants % in each case meaning percent by weight.
  • Emulsifiable concentrates active ingredient: 1 to 95%, preferably 5 to 20% surfactant: 1 to 30%, preferably 10 to 20 % solvent: 5 to 98%, preferably 70 to 85%
  • Dusts active ingredient: 0.1 to 10%, preferably 0.1 to 1% solid carrier: 99.9 to 90%, preferably 99.9 to 99%
  • Suspension concentrates active ingredient: 5 to 75%, preferably 10 to 50% water: 94 to 24%, preferably 88 to 30% surfactant: 1 to 40%, preferably 2 to 30% Wettable powders: active ingredient: 0.5 to 90%, preferably 1 to 80% surfactant: 0.5 to 20%, preferably 1 to 15% solid carrier: 5 to 99%, preferably 15 to 98%
  • Granulates active ingredient: 0.5 to 30%, preferably 3 to 15% solid carrier: 99.5 to 70%, preferably 97 to 85%
  • compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally or acaricidally active ingredients.
  • Suitable additions to active ingredients are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol deri ⁇ vatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridyl- methyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.
  • Examples of suitable mixing partners for the compounds of formula I include the following compounds selected from the group M 1 :
  • Group Mi an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628), an acaricide selected from the group of substances consisting of 1 ,1 -bis(4-chloro- phenyl)-2-ethoxyethanoI (IUPAC name) (910), 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059), 2-fluoro- ⁇ /-methyl- ⁇ /-1-naphthylacetamide (IUPAC name) (1295), 4-chlorophenyl phenyl sulfone (IUPAC name) (981 ), abamectin (1), acequinocyl (3), acetoprole [CCN], acrinathrin (9), aldicarb (16), aldoxycarb (863), alpha- cypermethrin (202), amidithion (870), amidoflumet [CCN], amidothioate (872), amit
  • megidis (alternative name) (433), Hippodamia convergens (alternative name) (442), Leptomastix dactylopii (alternative name) (488), Macrolophus caliginosus (alternative name) (491 ), Mamestra brassicae NPV (alternative name) (494), Metaphycus helvolus (alternative name) (522), Metarhizium anisopliae var. acridum (scientific name) (523), Metarhizium anisopliae var. anisopliae (scientific name) (523), Neodiprion sertifer NPV and N.
  • lecontei NPV (alternative name) (575), Orius spp. (alternative name) (596), Paecilomyces fumosoroseus (alternative name) (613), Phytoseiulus persimilis (alternative name) (644), Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ), Steinernema bibionis (alternative name) (742), Steinernema carpocapsae (alternative name) (742), Steinernema feltiae (alternative name) (742), Steinernema glaseri (alternative name) (742), Steinernema riohrave (alternative name) (742), Steinernema riobravis (alternative name) (742), Steinernema scapterisci (alternative name) (742), Steinernema spp.
  • DNOC doramectin (alternative name) [CCN], DSP (1115), ecdysterone (alternative name) [CCN], El 1642 (development code) (1118), emamectin (291), emamectin benzoate (291), EMPC (1120), empenthrin (292), endosulfan (294), endothion (1 121), endrin (1122), EPBP (1123), EPN (297), epofenonane (1124), eprinomectin (alternative name) [CCN], esfenvalerate (302), etaphos (alternative name) [CCN], ethiofencarb (308), ethion (309), ethiprole (310), ethoate-methyl (1134), ethoprophos (312), ethyl formate (IUPAC name) [CCN], ethyl-DDD (alternative name) (1056),
  • the compounds of the group M 1 are known. Where the compounds of the group M 1 are included in "The Pesticide Manual” [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. Tomlin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound “abamectin” is described under entry number (1). Where “[CCN]” is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright ⁇ 1995-2004]; for example, the compound “acetoprole” is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.
  • Examples of especially suitable mixing partners for the compounds of formula I include the following compounds selected from the group M: Group M:
  • M means one member selected from the group M.
  • compositions can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • compositions that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scatte ⁇ ring or pouring - which are to be selected to suit the intended aims of the prevailing circum ⁇ stances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention.
  • Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient.
  • the rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.
  • a preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question.
  • the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.
  • compositions according to the invention are also suitable for the protection of plant pro ⁇ pagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type.
  • the propagation material can be treated with the compositions prior to planting, for example seed can be treated prior to sowing.
  • the compositions can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling.
  • Example P2 Preparation of N 2 -(2-Ethyl-1-methyl-cvclopropyD-3-iodo-N 1 -r2-methyl-4-(1 , 2.2,2- tetrafluoro-1-trifluoromethyl-ethyl)-phenvn-phthalamide:
  • Example P4 Preparation of N 2 -(2-Bicvclor4.1.0lhept-1-yl-ethv ⁇ -3-chloro- N 1 -r2-methyl-4- (1 ,2,2,2-tetrafluoro-1-trifluoromethyl-ethyl)-phenv ⁇ -phthalamide:
  • a solution of trifluoroacetic acid (3.42g, 30 mmol) in dichloromethane (30 ml) is added dropwise to a solution of diethylzinc in hexane (1 M, 30 ml) and dichloromethane (20 ml) at a temperature of -20 0 C over ca 30 minutes keeping the temperature below 0 0 C.
  • methylene iodide (2.42ml, 30 mmol) is added, and this reagent solution kept under nitrogen at 0 0 C.
  • the Table A discloses 588 meanings of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 in a compound of the formula I-A.
  • Table 1 This table discloses the 588 compounds T1.1.1 to T1.1.588 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 588 lines A.1.1 to A.1.588, of the Table A.
  • the specific compound T1.1.23 is the compound of the formula T1 , in which each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the line A.1.23 of the Table A. According to the same system, also all of the other 587 specific compounds disclosed in the Table 1 as well as all of the specific compounds disclosed in the Tables 2 to 36 are specified analogously.
  • Table 2 This table discloses the 588 compounds T2.1.1 to T2.1.588 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 588 lines A.1.1 to A.1.588, of the Table A.
  • Table 3 This table discloses the 588 compounds T3.1.1 to T3.1.588 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 588 lines A.1.1 to A.1.588, of the Table A.
  • the Table B discloses 54 meanings of the variables Z 2 , Z 3 , Z 4 , Z 5 and R 4 in a compound of the formula I-B.
  • Table 4 This table discloses the 54 compounds T4.2.1 to T4.2.54 of the formula
  • each of the variables Z 2 , Z 04 , Z 4 , Z 5 and R 4 has the specific meaning given in the corresponding line, appropriately selected from the 54 lines B.2.1 to B.2.54, of the Table B.
  • Table 5 This table discloses the 54 compounds T5.2.1 to T5.2.54 of the formula
  • each of the variables Z 2 , Z 04 , Z 4 , Z 5 and R 4 has the specific meaning given in the corresponding line, appropriately selected from the 54 lines B.2.1 to B.2.54, of the Table B.
  • Table 6 discloses the 54 compounds T6.2.1 to T6.2.54 of the formula in which, for each of these 54 specific compounds, each of the variables Z 2 , Z 04 , Z 4 , Z 5 and R 4 has the specific meaning given in the corresponding line, appropriately selected from the 54 lines B.2.1 to B.2.54, of the Table B.
  • the Table C discloses 309 meanings of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 in a compound of the formula I-C.
  • Table 7 This table discloses the 309 compounds T7.3.1 to T7.3.309 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 309 lines C.3.1 to C.3.309, of the Table C.
  • Table 8 This table discloses the 309 compounds T8.3.1 to T8.3.309 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 309 lines C.3.1 to C.3.309, of the Table C.
  • Table 9 This table discloses the 309 compounds T9.3.1 to T9.3.309 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 309 lines C.3.1 to C.3.309, of the Table C.
  • the Table D discloses 24 meanings of the variables Z 5 , R 5 , R 6 , R 7 and R 8 in a compound of the formula I-D.
  • Table 10 This table discloses the 24 compounds T10.4.1 to T10.4.24 of the formula
  • each of the variables Z 5 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 24 lines D.4.1 to D.4.24, of the Table D.
  • Table 1 1 This table discloses the 24 compounds T11.4.1 to T11.4.24 of the formula
  • each of the variables Z 5 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 24 lines D.4.1 to D.4.24, of the Table D.
  • Table 12 This table discloses the 24 compounds T12.4.1 to T12.4.24 of the formula
  • each of the variables Z 5 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 24 lines D.4.1 to D.4.24, of the Table D.
  • the Table E discloses 8 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula I-E.
  • Table 13 This table discloses the 8 compounds T13.5.1 to T13.5.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines E.5.1 to E.5.8, of the Table E.
  • Table 14 This table discloses the 8 compounds T14.5.1 to T14.5.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines E.5.1 to E.5.8, of the Table E.
  • Table 15 This table discloses the 8 compounds T15.5.1 to T15.5.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines E.5.1 to E.5.8, of the Table E.
  • Table F discloses 114 meanings of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 in a compound of the formula I-F.
  • Table 16 This table discloses the 114 compounds T16.6.1 to T16.6.114 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 114 lines F.6.1 to F.6.114, of the Table F.
  • Table 17 This table discloses the 114 compounds T17.6.1 to T17.6.1 14 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 1 14 lines F.6.1 to F.6.1 14, of the Table F.
  • Table 18 This table discloses the 114 compounds T18.6.1 to T18.6.114 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 114 lines F.6.1 to F.6.114, of the Table F.
  • the Table G discloses 27 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula I-G.
  • Table 19 This table discloses the 27 compounds T19.7.1 to T19.7.27 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 27 lines G.7.1 to G.7.27, of the Table G.
  • Table 20 This table discloses the 27 compounds T20.7.1 to T20.7.27 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 27 lines G.7.1 to G.7.27, of the Table G.
  • Table 21 This table discloses the 27 compounds T21.7.1 to T21.7.27 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 27 lines G.7.1 to G.7.27, of the Table G.
  • Table H discloses 8 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula I-H.
  • Table 22 This table discloses the 8 compounds T22.8.1 to T22.8.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines H.8.1 to H.8.8, of the Table H.
  • Table 23 This table discloses the 8 compounds T23.8.1 to T23.8.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines H.8.1 to H.8.8, of the Table H.
  • Table 24 This table discloses the 8 compounds T24.8.1 to T24.8.8 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 8 lines H.8.1 to H.8.8, of the Table H.
  • Table I discloses 18 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula l-l.
  • Table 25 This table discloses the 18 compounds T25.9.1 to T25.9.18 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines 1.9.1 to 1.9.18, of the Table I.
  • Table 26 This table discloses the 18 compounds T26.9.1 to T26.9.18 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines 1.9.1 to 1.9.18, of the Table I.
  • Table 27 This table discloses the 18 compounds T27.9.1 to T27.9.18 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 18 lines 1.9.1 to 1.9.18, of the Table I.
  • the Table J discloses 95 meanings of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 in a compound of the formula I-J.
  • Table 28 This table discloses the 95 compounds T28.10.1 to T28.10.95 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 95 lines J.10.1 to J.10.95, of the Table J.
  • Table 29 This table discloses the 95 compounds T29.10.1 to T29.10.95 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 95 lines J.10.1 to J.10.95, of the Table J.
  • Table 30 This table discloses the 95 compounds T30.10.1 to T30.10.95 of the formula
  • each of the variables Z 5 , R 4 , R 5 , R 6 , R 7 and R 8 has the specific meaning given in the corresponding line, appropriately selected from the 95 lines J.10.1 to J.10.95, of the Table J.
  • the Table K discloses 6 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula I-K.
  • Table 31 This table discloses the 6 compounds T31.11.1 to T31.11.6 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 6 lines K.11.1 to K.11.6, of the Table K.
  • Table 32 This table discloses the 6 compounds T32.11.1 to T32.11.6 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 6 lines K.11.1 to K.11.6, of the Table K.
  • Table 33 This table discloses the 6 compounds T33.11.1 to T33.11.6 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 6 lines K.11.1 to K.11.6, of the Table K.
  • the Table L discloses 9 meanings of the variables Z 5 , R 5 , R 6 and R 7 in a compound of the formula I-L.
  • Table 34 This table discloses the 9 compounds T34.12.1 to T34.12.9 of the formula
  • each of the variables Z 5 , R 5 , R 6 and R 7 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines L 12.1 to L.12.9, of the Table L
  • Table 35 discloses the 9 compounds T35.12.1 to T35.12.9 of the formula in which, for each of these 9 specific compounds, each of the variables Z 5 , R 5 , R 6 and R 7 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines L 12.1 to L 12.9, of the Table L
  • Table 36 This table discloses the 9 compounds T36.12.1 to T36.12.9 of the formula
  • each of the variables Z 5 , R 5 , R 6 and R 7 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines L.12.1 to L.12.9, of the Table L
  • the Table M discloses 9 meanings of the variables Z 5 , R 5 and R 6 in a compound of the formula I-M.
  • Table 37 This table discloses the 9 compounds T37.13.1 to T37.13.9 of the formula
  • each of the variables Z 5 , R 5 and R 6 has the specific meaning given in the corresponding line, appropriately selected from the 9 lines M.13.1 to M.13.9, of the Table M.
  • Example F1 Emulsion concentrates a) b) C)
  • Emulsions of any desired concentration can be prepared from such concentrates by dilution with water.
  • Example F2 Solutions a) b) c) d)
  • Petroleum ether (boiling range: 160-190°) - - 94%
  • the solutions are suitable for use in the form of microdrops.
  • Example F3 Granules a) b) c) d)
  • the active ingredient is dissolved in dichloromethane, the solution is sprayed onto the carrier(s), and the solvent is subsequently evaporated in vacuo.
  • Example F4 Dusts a) b) Active ingredient 2 % 5 % Highly disperse silica 1 % 5 % Talc 97 % - Kaolin _ 90 %
  • Ready-to-use dusts are obtained by intimately mixing the carriers and the active ingredient.
  • Example F5 Wettable powders a) b) c)
  • the active ingredient is mixed with the additives and the mixture is ground thoroughly in a suitable mill. This gives wettable powders, which can be diluted with water to give suspensions of any desired concentration.
  • Example F6 Extruder granules Active ingredient 10 %
  • the active ingredient is mixed with the additives, and the mixture is ground, moistened with water, extruded, granulated and dried in a stream of air.
  • Example F7 Coated granules
  • the finely ground active ingredient is applied uniformly to the kaolin, which has been moistened with the polyethylene glycol. This gives dust-free coated granules.
  • Nonylphenoxypolyethylene glycol ether (15 mol of EO) 6 %
  • the finely ground active ingredient is mixed intimately with the additives.
  • Suspensions of any desired concentration can be prepared from the thus resulting suspension concentrate by dilution with water.
  • Example B1 Activity against Aphis craccivora
  • Pea seedlings are infected with Aphis craccivora, subsequently sprayed with a spray mixture comprising 400 ppm of active ingredient and then incubated at 20°. 3 and 6 days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead aphids between the treated and untreated plants.
  • Maize seedlings are sprayed with an aqueous emulsion spray mixture comprising 400 ppm of active ingredient and, after the spray coating has dried on, populated with 10 larvae (2nd instar) of Diabrotica balteata and introduced into a plastic container. 6 days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead larvae between the treated and untreated plants.
  • Example B3 Activity against Heliothis virescens (foliar application)
  • Young soya plants are sprayed with an aqueous emulsion spray mixture comprising 400 ppm of active ingredient and, after the spray coating has dried on, populated with 10 caterpillars (1st instar) of Heliothis virescens and introduced into a plastic container. 6 days later, the percentage reduction in the population and in the feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage between the treated and untreated plants.
  • T1.1.25, T1.1.340, T1.1.36, T25.9.15, T1.1.562 have an activity of over 80 %.
  • Example B4 Activity against Heliothis virescens (application to eggs)
  • Heliothis virescens eggs which have been deposited on cotton, are sprayed with an aqueous emulsion spray mixture comprising 400 ppm of active ingredient. After 8 days, the percentage hatching rate of the eggs and the survival rate of the caterpillars (% activity) are evaluated in comparison with untreated control batches.
  • Pea seedlings are infected with Myzus persicae, subsequently sprayed with a spray mixture comprising 400 ppm of active ingredient and then incubated at 20°. 3 and 6 days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead aphids between the treated and untreated plants.
  • Example B6 Activity against Mvzus persicae (systemic application)
  • Pea seedlings are infected with Myzus persicae, and their roots are subsequently placed into a spray mixture comprising 400 ppm of active ingredient. The seedlings are then incubated at 20°. 3 and 6 days later, the percentage reduction in the population (% activity) is determined by comparing the number of dead aphids between the treated and untreated plants.
  • Example B7 Activity against Plutella xylostella
  • Young cabbage plants are sprayed with an aqueous emulsion spray mixture compri ⁇ sing 400 ppm of active ingredient and, after the spray coating has dried on, popula ⁇ ted with 10 caterpillars (3rd instar) of Plutella xylostella and introduced into a plastic container. 3 days later, the percentage reduction in the population and in the feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage between the treated and untreated plants. In this test, compounds listed in the Tables above show good activity.
  • the compounds T ⁇ .1.135, T1.1.121 , T1.1.149, T ⁇ .1.117, T ⁇ .1.179, T1.1.115, T ⁇ .1.180, T1.1.147, T1.1.119, T1.1.212, T1.1.562, T1.1.5, T1.1.17, T1.1.22, T1.1.25, T ⁇ .1.340, T1.1.36, T25.9.15, T1.1.562 have an activity of over 80 %.
  • Young soya plants are sprayed with an aqueous emulsion spray mixture comprising 400 ppm of active ingredient and, after the spray coating has dried on, populated with 10 caterpillars (1st instar) of Spodoptera littoralis and introduced into a plastic container. 3 days later, the percentage reduction in the population and in the feeding damage (% activity) are determined by comparing the number of dead caterpillars and the feeding damage between the treated and untreated plants. In this test, compounds listed in the Tables above show good activity.
  • the compounds T1.1.121 , T1.1.149, T1.1.117, T1.1.179, T1.1.115, T1.1.119, T1.1.212, T1.1.5, T1.1.17, T1.1.22, T1.1.25, T1.1.340, T1.1.36, T25.9.15 have an activity of over 80 %.

Abstract

L'invention concerne des composés représentés par la formule (I), dans laquelle les substituants sont tels que définis dans la revendication (1), ainsi que les sels acceptables d'un point de vue agrochimique et tous les stéréo-isomères et les formes tautomères des composés de la formule (I), qui sont utiles comme matières agrochimiques actives et peuvent être préparées d'une manière connue en soi.
PCT/EP2005/009392 2004-09-01 2005-08-31 Dérivés de phtalamide s'utilisant comme insecticides WO2006024523A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0419420.5 2004-09-01
GBGB0419420.5A GB0419420D0 (en) 2004-09-01 2004-09-01 Novel insecticides

Publications (1)

Publication Number Publication Date
WO2006024523A1 true WO2006024523A1 (fr) 2006-03-09

Family

ID=33155861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/009392 WO2006024523A1 (fr) 2004-09-01 2005-08-31 Dérivés de phtalamide s'utilisant comme insecticides

Country Status (3)

Country Link
GB (1) GB0419420D0 (fr)
TW (1) TW200628432A (fr)
WO (1) WO2006024523A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539902A (ja) * 2006-06-13 2009-11-19 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 複素芳香族及び複素環置換基を有するアントラニル酸ジアミド誘導体
CN105325448A (zh) * 2015-12-16 2016-02-17 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和噻虫嗪的杀虫组合物
CN105340924A (zh) * 2015-12-16 2016-02-24 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和苦参碱的杀虫组合物
CN105475337A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和吡虫啉的杀虫组合物
CN105475293A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和溴虫苯甲酰胺的杀虫组合物
CN105475332A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和氟啶虫胺腈的杀虫组合物
CN105475329A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和茚虫威的杀虫组合物

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940419A (en) * 1973-04-05 1976-02-24 American Cyanamid Company Phthalimide derivatives and their use as plant growth regulants
EP0427907A2 (fr) * 1989-11-12 1991-05-22 American Cyanamid Company Phtalimido-cyclohexane-carboxamides substituées et leur utilisation pour promouvoir la croissance de plantes hybrides de rose-thé
US20010041814A1 (en) * 1997-11-25 2001-11-15 Masanori Tohnishi Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
WO2002094766A1 (fr) * 2001-05-18 2002-11-28 Nihon Nohyaku Co., Ltd. Derive de phtalamide, insecticide agricole et horticole et son utilisation
US6603044B1 (en) * 1998-11-30 2003-08-05 Nihon Nohyaku Co., Ltd. Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
WO2004000796A1 (fr) * 2002-06-20 2003-12-31 Bayer Cropscience Ag Nouveaux derives de phthalamide
EP1380209A1 (fr) * 2001-04-17 2004-01-14 Nihon Nohyaku Co., Ltd. Composition d'agents pesticides et procede d'utilisation
US20040009982A1 (en) * 1999-12-22 2004-01-15 Masanori Tohnishi Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940419A (en) * 1973-04-05 1976-02-24 American Cyanamid Company Phthalimide derivatives and their use as plant growth regulants
EP0427907A2 (fr) * 1989-11-12 1991-05-22 American Cyanamid Company Phtalimido-cyclohexane-carboxamides substituées et leur utilisation pour promouvoir la croissance de plantes hybrides de rose-thé
US20010041814A1 (en) * 1997-11-25 2001-11-15 Masanori Tohnishi Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
US6603044B1 (en) * 1998-11-30 2003-08-05 Nihon Nohyaku Co., Ltd. Phthalamide derivatives, or salt thereof agrohorticultural insecticide, and method for using the same
US20040009982A1 (en) * 1999-12-22 2004-01-15 Masanori Tohnishi Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
EP1380209A1 (fr) * 2001-04-17 2004-01-14 Nihon Nohyaku Co., Ltd. Composition d'agents pesticides et procede d'utilisation
WO2002094766A1 (fr) * 2001-05-18 2002-11-28 Nihon Nohyaku Co., Ltd. Derive de phtalamide, insecticide agricole et horticole et son utilisation
WO2004000796A1 (fr) * 2002-06-20 2003-12-31 Bayer Cropscience Ag Nouveaux derives de phthalamide

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539902A (ja) * 2006-06-13 2009-11-19 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 複素芳香族及び複素環置換基を有するアントラニル酸ジアミド誘導体
CN105325448A (zh) * 2015-12-16 2016-02-17 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和噻虫嗪的杀虫组合物
CN105340924A (zh) * 2015-12-16 2016-02-24 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和苦参碱的杀虫组合物
CN105475337A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和吡虫啉的杀虫组合物
CN105475293A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和溴虫苯甲酰胺的杀虫组合物
CN105475332A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和氟啶虫胺腈的杀虫组合物
CN105475329A (zh) * 2015-12-16 2016-04-13 济南昊泽环保科技有限公司 一种含有邻苯二胺类杀虫剂和茚虫威的杀虫组合物

Also Published As

Publication number Publication date
TW200628432A (en) 2006-08-16
GB0419420D0 (en) 2004-10-06

Similar Documents

Publication Publication Date Title
EP1871760B1 (fr) Insecticides de type cyanoanthranilamides
AU2007204417B2 (en) Anthranilamide derivatives and their use for the control of insects and acari
AU2005293801B2 (en) Heterocyclic diamide insecticidal agents
EP1984354B1 (fr) Pesticides contenant une structure bis(amide) bicyclique
EP2167484B1 (fr) Anthranilamides condensés en tant qu' insecticides
EP1919903A2 (fr) Bisamides bicycliques et leurs utilisation comme insecticides.
EP2099785B1 (fr) N-cyanoalkylanthranilamides à usage insecticide
WO2006024523A1 (fr) Dérivés de phtalamide s'utilisant comme insecticides
US7612018B2 (en) Insecticides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WA Withdrawal of international application
NENP Non-entry into the national phase

Ref country code: DE